Background: The emergence of metallo-beta-lactamase ( MBL) producing isolates is a challenge to routine microbiology laboratories, since there are no standardized methods for detecting them. Aim: To study the prevalence of MBL producing Gram negative bacteria and non-fermenters and compare and evaluate the use of two phenotypic methods, double-disk synergy test ( DDST) and a combination disk diffusion test ( CDDT) method from various clinical samples. Materials & Methods: A prospective study was done to test for MBL production by DDST and CDDT from select isolates that were Carbapenem and Ceftazidime resistant by Kirby Bauer disc diffusion test. Results: Of the 108 isolates 48 (44.4%) were resistant to Imipenem or Meropenem or both and...
Objectives: This study aimed to develop a novel model for detection of extended spectrum beta-lactam...
Extended spectrum beta lactamases (ESBL) hydrolyse expanded spectrum cephalosporins like ceftazidime...
Introduction: Carbapenems are the primary choice of treatment for nosocomial Pseudomonas aeruginosa ...
Published: May 20, 2016Background: The rapid spread of acquired Metallo-Beta-Lactamases (MBL) among ...
Background: Extensive use of β- lactam group of antibiotics to treat the gram negative bacterial inf...
The purpose of this study was to determine the frequency of extended-spectrum beta-lactamases (ESBLs...
Introduction: The emergence and rapid spread of multidrug resistant Pseudomonas aeruginosa causing n...
Summary: Background: The rapid spread of metallo-β-lactamase producing clinical pathogens is a matt...
Broad spectrum antimicrobial resistance, where resistance to multiple, or even all available antibio...
Background and objectives: The emergence of multidrug resistance among Pseudomonas species and Acine...
Background: Extended-spectrum beta (β)-lactamase (ESBL)-producing enterobacteria are major emerging ...
Introduction: Metallo-beta lactamase production is the most common mechanism of carbapenem resistanc...
Introduction: Pseudomonas aeruginosa is one of the major bacterial nosocomial infections. Metallo-β-...
Objectives: 1) To determine the prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa i...
Introduction: Non-fermentative gram-negative bacilli are common causes of human infections especiall...
Objectives: This study aimed to develop a novel model for detection of extended spectrum beta-lactam...
Extended spectrum beta lactamases (ESBL) hydrolyse expanded spectrum cephalosporins like ceftazidime...
Introduction: Carbapenems are the primary choice of treatment for nosocomial Pseudomonas aeruginosa ...
Published: May 20, 2016Background: The rapid spread of acquired Metallo-Beta-Lactamases (MBL) among ...
Background: Extensive use of β- lactam group of antibiotics to treat the gram negative bacterial inf...
The purpose of this study was to determine the frequency of extended-spectrum beta-lactamases (ESBLs...
Introduction: The emergence and rapid spread of multidrug resistant Pseudomonas aeruginosa causing n...
Summary: Background: The rapid spread of metallo-β-lactamase producing clinical pathogens is a matt...
Broad spectrum antimicrobial resistance, where resistance to multiple, or even all available antibio...
Background and objectives: The emergence of multidrug resistance among Pseudomonas species and Acine...
Background: Extended-spectrum beta (β)-lactamase (ESBL)-producing enterobacteria are major emerging ...
Introduction: Metallo-beta lactamase production is the most common mechanism of carbapenem resistanc...
Introduction: Pseudomonas aeruginosa is one of the major bacterial nosocomial infections. Metallo-β-...
Objectives: 1) To determine the prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa i...
Introduction: Non-fermentative gram-negative bacilli are common causes of human infections especiall...
Objectives: This study aimed to develop a novel model for detection of extended spectrum beta-lactam...
Extended spectrum beta lactamases (ESBL) hydrolyse expanded spectrum cephalosporins like ceftazidime...
Introduction: Carbapenems are the primary choice of treatment for nosocomial Pseudomonas aeruginosa ...